Clinical effect of Sodium Tanshinone ⅡA Sulfonate Injection in the treatment of senile pulmonary heart disease
QIN Hongjie1 CHEN Xinguang2
1.Department of Emergency, Beijing Luhe Hospital, Capital Medical University, Beijing 101199, China;
2.Department of Emergency, Beijing Puren Hospital, Beijing 100062, China
Abstract：Objective To investigate the clinical effect of Sodium Tanshinone ⅡA Sulfonate Injection in the treatment of senile pulmonary heart disease. Methods Eighty-six cases of elderly patients with acute stage of pulmonary heart disease treated in Beijing Luhe Hospital, Capital Medical University from June 2013 to June 2015 were selected and divided into control group and observation group by random number table method, with 43 cases in each group. Both groups were given conventional treatment, on basis of which, the observation group was added with Sodium Tanshinone ⅡA Sulfonate Injection, intravenous drip. The clinical effect of the two groups was observed, the indexes of hemorheology, arterial blood gas analysis, pulmonary artery systolic pressure of the two groups before and after treatment were compared, the adverse reactions of the two groups during the course of treatment were recorded. Results The total effective rate of observation group (88.37%) was higher than that of control group (76.74%), the difference was statistically significant (P ＜ 0.05). After treatment, the indexes of hemorheology (whole high blood viscosity, whole low blood viscosity, plasma viscosity, hematocrit, red cell assembling index, platelet aggregation rate, fibrinogen) in the two groups were all lower than those before treatment, the differences were statistically significant (P ＜ 0.05); after treatment, the indexes of hemorheology above in the observation group were all lower than those of control group, the differences were statistically significant (P ＜ 0.05). Compared with before treatment, the PaO2 of the two groups after treatment were increased, PaCO2 and pulmonary artery systolic pressure were decreased, the differences were statistically significant (P ＜ 0.05). After treatment, the PaO2 of observation group was higher than that of control group, the PaCO2 and pulmonary artery systolic pressure were lower than those of control group, the differences were statistically significant (P ＜ 0.05). Both groups had no obvious adverse reactions during the treatment. Conclusion Sodium Tanshinone ⅡA Sulfonate Injection in the treatment of senile pulmonary heart disease has significant effects, which can reduce the clinical signs and symptoms, improve the cardiac function and the states of hemorheology and pulmonary arterial hypertension, and the safety is high, which is worthy of clinical promotion and application.
2017, Vol. 14 
京公网安备 11010502046598号